![Bernhardt Zeiher](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bernhardt Zeiher
Director/Board Member at ENTRADA THERAPEUTICS, INC.
Net worth: - $ as of 2024-05-30
Profile
Bernhardt G.
Zeiher is currently serving as an Independent Director at Entrada Therapeutics, Inc., Amylyx Pharmaceuticals, Inc., and as a Director at Transcelerate Biopharma, Inc. Previously, he held positions as an Associate Medical Director at Merck & Co., Inc. from 1998 to 2000, President at Astellas Pharma Global Development, Inc. from 2015 to 2019, and Chief Medical Officer at Astellas Pharma, Inc. from 2018 to 2022.
He obtained his undergraduate degree from the University of Toledo (Ohio) and his doctorate from Case Western Reserve University School of Medicine.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ENTRADA THERAPEUTICS INC
-.--% | 2024-06-12 | 0 ( -.--% ) | - $ | 2024-05-30 |
Bernhardt Zeiher active positions
Companies | Position | Start |
---|---|---|
ENTRADA THERAPEUTICS, INC. | Director/Board Member | 2023-04-03 |
AMYLYX PHARMACEUTICALS, INC. | Director/Board Member | 2024-03-13 |
Transcelerate Biopharma, Inc.
![]() Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Director/Board Member | 2024-02-29 |
Former positions of Bernhardt Zeiher
Companies | Position | End |
---|---|---|
ASTELLAS PHARMA INC. | Chief Tech/Sci/R&D Officer | 2021-12-31 |
Astellas Pharma Global Development, Inc.
![]() Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | President | 2018-12-31 |
MERCK & CO., INC. | Corporate Officer/Principal | 1999-12-31 |
Training of Bernhardt Zeiher
University of Toledo (Ohio) | Undergraduate Degree |
Case Western Reserve University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
ASTELLAS PHARMA INC. | Health Technology |
ENTRADA THERAPEUTICS, INC. | Health Technology |
AMYLYX PHARMACEUTICALS, INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
Private companies | 2 |
---|---|
Astellas Pharma Global Development, Inc.
![]() Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Health Technology |
Transcelerate Biopharma, Inc.
![]() Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Health Technology |
- Stock Market
- Insiders
- Bernhardt Zeiher